Related Experiment Videos
Functionally gene-linked polymorphic regions and genetically controlled neurotransmitters metabolism.
1IRCCS, H. San Raffaele, DSNP, Milan, Italy.
Summary
Pharmacogenetics offers insights into psychiatric drug response variability. Gene variations in serotonin transporter, monoamine oxidase A, and catechol-O-methyltransferase may explain differences in treatment outcomes and side effects.
Area of Science:
- Psychiatry
- Neuroscience
- Genetics
Background:
- Inter-individual variability in clinical psychopharmacology outcomes and side effects is well-documented.
- Pharmacogenetics is increasingly important in psychiatry for understanding these differences.
- Variations in gene expression and neurotransmitter metabolism may explain psychopathology and drug response.
Purpose of the Study:
- To explore the role of functional gene polymorphisms in clinical psychopharmacology.
- To discuss specific genetic variations and their potential relationship with clinical variables.
Main Methods:
- Review of functional polymorphisms in candidate genes.
- Focus on genetic variations within regulatory and coding regions.
- Application of sophisticated molecular approaches in neuropsychopharmacology.
Main Results:
- The 44-bp insertion/deletion polymorphism in the serotonin transporter gene promoter.
- A repeat polymorphism in the promoter region of the monoamine oxidase A gene.
- A functional polymorphism within the coding region of the catechol-O-methyltransferase gene.
Conclusions:
- Functional gene polymorphisms are crucial for understanding individual responses to psychotropic medications.
- Investigating these genetic variations can advance personalized medicine in psychiatry.
- Further research into gene-environment interactions is warranted.